Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.
Johansson H, Gray KP, Pagani O, Regan MM, Viale G, Aristarco V, Macis D, Puccio A, Roux S, Maibach R, Colleoni M, Rabaglio M, Price KN, Coates AS, Gelber RD, Goldhirsch A, Kammler R, Bonanni B, Walley BA; the TEXT principal investigators. Johansson H, et al. Breast Cancer Res. 2016 Nov 8;18(1):110. doi: 10.1186/s13058-016-0771-8. Breast Cancer Res. 2016. PMID: 27825388 Free PMC article.
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.
Decensi A, Robertson C, Viale G, Pigatto F, Johansson H, Kisanga ER, Veronesi P, Torrisi R, Cazzaniga M, Mora S, Sandri MT, Pelosi G, Luini A, Goldhirsch A, Lien EA, Veronesi U. Decensi A, et al. Among authors: johansson h. J Natl Cancer Inst. 2003 Jun 4;95(11):779-90. doi: 10.1093/jnci/95.11.779. J Natl Cancer Inst. 2003. PMID: 12783932 Free article. Clinical Trial.
A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.
Decensi A, Bonanni B, Baglietto L, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Robertson C, Marinucci I, Mariette F, Sandri MT, Daldoss C, Bianco V, Buttarelli M, Cazzaniga M, Franchi D, Cassano E, Omodei U. Decensi A, et al. Among authors: johansson h. Clin Cancer Res. 2004 Jul 1;10(13):4389-97. doi: 10.1158/1078-0432.CCR-04-0087. Clin Cancer Res. 2004. PMID: 15240527 Clinical Trial.
Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.
Guerrieri-Gonzaga A, Robertson C, Bonanni B, Serrano D, Cazzaniga M, Mora S, Gulisano M, Johansson H, Formelli F, Intra M, Latronico A, Franchi D, Pelosi G, Johnson K, Decensi A. Guerrieri-Gonzaga A, et al. Among authors: johansson h. J Clin Oncol. 2006 Jan 1;24(1):129-35. doi: 10.1200/JCO.2005.02.9934. J Clin Oncol. 2006. PMID: 16382122 Clinical Trial.
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Macis D, Maisonneuve P, Johansson H, Bonanni B, Botteri E, Iodice S, Santillo B, Penco S, Gucciardo G, D'Aiuto G, Rosselli Del Turco M, Amadori M, Costa A, Decensi A. Macis D, et al. Among authors: johansson h. Breast Cancer Res Treat. 2007 Dec;106(2):263-71. doi: 10.1007/s10549-006-9491-6. Epub 2007 Jan 27. Breast Cancer Res Treat. 2007. PMID: 17260091
1,437 results